Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,566 | -24,931 | -19,518 | N/A | -5,303 |
| Depreciation Amortization | 91 | 53 | 28 | N/A | 8 |
| Other Working Capital | -3,513 | -3,520 | -1,172 | N/A | -507 |
| Other Operating Activity | 20,817 | 18,857 | 16,552 | 0 | 452 |
| Operating Cash Flow | $-14,171 | $-9,541 | $-4,110 | $N/A | $-5,350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | 3 | N/A | N/A | N/A |
| Net Acquisitions | 969 | 969 | 969 | N/A | N/A |
| Investing Cash Flow | $964 | $972 | $969 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 500 | N/A | N/A | N/A |
| Common Stock Issued | 26,039 | 22,839 | 22,853 | N/A | 6,610 |
| Dividend Paid | -6 | -4 | -2 | N/A | -6 |
| Other Financing Activity | 0 | 0 | 500 | 0 | 0 |
| Financing Cash Flow | $26,533 | $23,335 | $23,351 | $N/A | $6,604 |
| Beginning Cash Position | 2,392 | 2,392 | 2,392 | N/A | 3,719 |
| End Cash Position | 15,718 | 17,158 | 22,602 | N/A | 4,973 |
| Net Cash Flow | $13,326 | $14,766 | $20,210 | $N/A | $1,254 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,171 | -9,541 | -4,110 | N/A | -5,350 |
| Capital Expenditure | -8 | N/A | N/A | N/A | 0 |
| Free Cash Flow | -14,179 | -9,541 | -4,110 | 0 | -5,350 |